Plasma levels of adrenomedullin in patients with adrenoleukodystrophy/ adrenomyeloneuropathy

Hormone Research

Volumn 63, Issue 2, 2005, Pages 90-94

  Letizia, C ^a   D'Erasmo, E ^a   Subioli, S ^a   Di Biase, A ^b   Benedetti, S ^b   Bizzarri, C ^b   Ubertini, G ^b   Cappa, M ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

Addison's disease; Adrenoleukodystrophy; Adrenomedullin; Adrenomyeloneuropathy; Central nervous system; Demyelination

Indexed keywords

ADRENOMEDULLIN; ALDOSTERONE;

ADDISON DISEASE; ADOLESCENT; ADRENAL INSUFFICIENCY; ADRENOLEUKODYSTROPHY; ADULT; ALDOSTERONE BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; MALE; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHOOL CHILD;

ADDISON DISEASE; ADOLESCENT; ADRENAL INSUFFICIENCY; ADRENOLEUKODYSTROPHY; ADRENOMEDULLIN; ADULT; CASE-CONTROL STUDIES; CHILD; HUMANS; MALE; MIDDLE AGED; PEPTIDES;

EID: 17844390677     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000083942     Document Type: Article

References (22)

1. Kitamura K, Kangawa K, Kawamoto M, Ichiki Y, Nakamura S, Matsuo H, Eto T: Adrenomedullin a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 1993;192:553-560.
2. Ichiki Y, Kitamura K, Kangawa K, Kamoto M, Matsuo H, Eto T: Distribution and characterization of immunoreactive adrenomedullin in human tissue and plasma. FEBS Lett 1994; 338:6-10.
3. Ishiyama Y, Kitamura K, Ichiki Y, Nakamura S, Kida O, Kangawa K, Eto T: Hemodynamic effects of a novel hypotensive peptide, human adrenomedullin. Eur J Pharmacol 1993;241: 271-273.
4. Sakata J, Shimokubo T, Kitamura K, Nakamura S, Nakagawa K, Matsuo H, Eto T: Molecular cloning and biological activities of rat adrenomedullin receptor. Biochem Biophys Res Commun 1993;195:921-927.
5. Letizia C, Cerci S, Centanni M, De Toma G, Subioli S, Scuro L, Scavo D: Circulating levels of adrenomedullin in patients with Addison's disease before and after corticosteroid treatment. Clin Endocrinol 1998;48:145-148.
6. Samson WK, Murphy T, Schell DA: A novel vasoactive peptide, adrenomedullin, inhibits pituitary adrenocorticotrophin release. Endocrinology 1995;136:2349-2352.
7. Andreis G, Neri G, Prayer-Galetti T, Rossi GP, Gottardo G, Malendowicz LK, Nussdorfer GG: Effects of adrenomedullin on the human adrenal glands: An in vitro study. J Clin Endocrinol Metab 1997;82:1167-1170.
8. Mosser J, Douar AM, Sarde CO, Kioshis P, Feil R, Moser H, Poutska AM, Mandel JM, Aubourg P: Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporter. Nature 1993;361:726-730.
9. Wanders RJA, van Roermund CWT, van Wijland MJA, Schutgens RBH, van der Bosch H, Tager TM: Direct evidence that the deficient oxidation of very long chain fatty acid in X-linked adrenoleukodystrophy is due to an impaired ability of peroxisomes to activate very long chain fatty acids. Biochem Biophys Res Commun 1988;153:618-624.
10. Moser HW: Komrower Lecture. Adrenoleukodystrophy: Natural history, treatment and outcome. J Inherit Metab Dis 1995;18:435-447.
11. Cappa M, Cambiaso P, del Balzo P, Benedetti S, Borrelli P: Hormonal evaluation of adrenoleukodystrophy; in Uziel G, Wanders RJA, Cappa M (eds): Adrenoleukodystrophy and Other Peroxisomal Disorders. Amsterdam, Elsevier, 1990, pp 81-92.
12. Blevins LS, Shankroff J, Moser HW, Ladenson PW: Elevated plasma adrenocorticotropin concentration as evidence of limited adrenocortical reserve in patients with adrenomyeloneuropathy. J Clin Endocrinol Metab 1994;78: 261-265.
13. Betterle C, Volpato M, Pedini B, Boscaro M, Tedesco F, Presotto F: The natural history of Addison disease in organ-specific autoimmune patients with adrenocortical antibodies. Immunological study; in Bhatt HR, James WHT, Besser GM, Bottazzo GF, Keen H (eds): Advances in Thomas Addison's Disease. Bristol, Journal of Endocrinology Ltd, 1994, vol 1, pp 51-58.
14. Cappa M, Cambiaso P, del Balzo P, Borrelli P, Bertini E, Rimoldi M, Uziel G: Adrenoleukodystrophy: Clinical and therapeutic updating; in Bhatt HR, James WHT, Besser GM, Bottazzo GF, Keen H (eds): Advances in Thomas Addison's Disease. Bristol, Journal of Endocrinology Ltd, 1994, vol 1, pp 171-180.
15. Di Biase A, Salvati S, Quaresima T, Pieroni F, Grisolia A, Cambiaso P, Cappa M: C24:0/C22:0 ratio in plasma sphingomyelin as a practical tool for the diagnosis of adrenoleukodystrophy and adrenomyeloneuropathy. Clin Chem Enzym Commun 1995;7:35-40.
16. Whitcomb RW, Linhehan WM, Knazek RA: Effects of long-chain saturated fatty acids on membrane microviscosity and adrenocorticotropin responsiveness of human adrenocortical cells in vitro. J Clin Invest 1988;1:185-188.
17. Nussdorfer GG, Rossi GP, Mazzocchi G: Role of adrenomedullin and related peptides in the regulation of the hypothalamo-pituitary-adrenalaxis. Peptides 1997;18:1079-1089.
18. Letizia C, Di Iorio R, De Toma G, Marinoni E, Cerci S, Celi M, Subioli S, D'Erasmo E: Circulating adrenomedullin is increased in patients with corticotropin-dependent Cushing's syndrome due to pituitary adenoma.Metabolism 2000;49:760-763.
19. Takahashi K, Satoh F, Sone M, Murakami O, Sasano H, Mouri T, Shibahara S: Expression of adrenomedullin mRNA in the human brain and pituitary. Peptides 1997;18:1051-1053.
20. Parkers DG, May CN: ACTH-suppressive and vasodilatator actions of adrenomedullin in conscious sheep. J Neuroendocrinol 1995;7: 923-929.
21. Jamaguchi T, Baba K, Doi Y, Yano K: Effect of adrenomedullin on aldosterone secretion by dispersed rat adrenal zona glomerulosa cells. Life Sci 1995;56:379-387.
22. Hinson JP, Kapas S, Smith DM: Adrenomedullin, a multifunctional regulatory peptides. Endocr Rev 2000;21:138-167.